C-RAD

Board/Management Information • May 13, 2024

Jonas Reinhammar is appointed interim CFO and takes office immediately

Since February 2024, Jonas Reinhammar has a full-time assignment at C-RAD's finance department. He will immediately assume his new role as interim CFO.

As previously announced, recruitment of a CFO is ongoing and the process continues according to plan.

For further information:

Cecilia de Leeuw, CEO, +46 (0)795 85 66 77, investors@c-rad.com

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

Attachments

Jonas Reinhammar is appointed interim CFO and takes office immediately